XOMA Corp

NASDAQ:XOMA  
22.26
-1.25 (-5.32%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)234.11M
Current PE27.16
Forward PE 21.82
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$35.14 Million
Adjusted EPS$2.27
See more estimates
10-Day MA$23.44
50-Day MA$24.55
200-Day MA$31.08
See more pivots

XOMA Corp Stock, NASDAQ:XOMA

2200 Powell Street, Suite 310, Emeryville, California 94608
United States of America
Phone: +1.510.204.7200
Number of Employees: 10

Description

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.